Femto Technologies Inc., a pioneering FemTech company, has successfully closed a private placement offering, raising approximately $17 million to further its technological development in women's wellness. The investment, completed on February 28, 2025, represents a significant financial milestone for the company and its flagship product, Sensera.
The private placement involved the sale of 4,076,736 Common Units, each comprising a common share or pre-funded warrant, along with two series of warrants. Investors purchased these units at $4.17 per unit, with the Series A and Series B warrants offering potential future investment opportunities at predetermined exercise prices.
The funding is strategically important for Femto Technologies, as it provides critical capital to advance the company's innovative Smart Release System (SRS) technology. Sensera, the company's flagship product, has already garnered industry recognition, being named a CES Innovation Awards® 2025 Honorary in the AI category. This accolade underscores the potential of the company's machine learning and artificial intelligence-driven approach to feminine wellness.
By leveraging the net proceeds from this private placement, Femto Technologies aims to expand its research and development efforts, enhance product manufacturing capabilities, and potentially explore new applications for its proprietary technology. The investment signals strong market interest in advanced, technology-driven solutions for women's health and wellness.
The private placement was conducted exclusively with accredited investors, and the securities were sold through a private transaction not involving a public offering. Aegis Capital Corp. served as the exclusive placement agent for the transaction, highlighting the financial industry's growing recognition of FemTech's potential.
While the company emphasizes that its current devices are in the early stages of development and subject to testing and regulatory approvals, the substantial funding suggests investor confidence in Femto Technologies' innovative approach and future potential. The successful private placement positions the company to continue pushing the boundaries of technology in feminine wellness.
